FDA Inspection 678092 — Boehringer Ingelheim Pharmaceuticals, Inc.
The FDA completed an inspection of Boehringer Ingelheim Pharmaceuticals, Inc. on Sep 1, 2010 in Ridgefield, CT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 1, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ridgefield, CT (United States)
Additional Details
Sponsor, Contract Research Organization
Citations
| ID | CFR | Description |
|---|---|---|
| 7482 | 21 CFR 312.50 | General responsibilities of sponsors |
| 7507 | 21 CFR 312.52(a) | Transfer of obligations |
| 7545 | 21 CFR 312.120(c) | Foreign clinical trials |